Bruxism. other somatoform disorders
Conditions
Interventions
Intervention 1: To subgroups 3 from both age group, placebo was gave as followa
2-8-year-old: half a placebo tablet
8-12-year-old: a placebo tablet
Other study process is similar for placebo and diazepam. Intervention 2: For age group of 2-8 years 2.5 mg Diazepam(code A- half a
Treatment - Drugs
To subgroups 3 from both age group, placebo was gave as followa
2-8-year-old: half a placebo tablet
8-12-year-old: a placebo tablet
Other study process is similar for placebo and diazepam.
For age group of 2-8 years 2.5 mg Diazepam(code A- half a 5 mg pill) is considered as low dose and 5 mg Diazepam( code B- half a 10 mg pill) as high dose. For age group of 8-15 years 5 mg Diazepam(co
Sponsors
Vice Chancellor for Research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 15 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria including: Bruxism reported by parents; No previous seizure disorder or abnormal movement during sleep; Age 2-15 years; Not taking any medications that affects the neuromuscular system, such as anticonvulsants, benzodiazepines, muscle relaxant and antidepressants; Visual Analogue Score (VAS) will be calculated for included patients by the score of duration, intensity and frequency of bruxism episodes. Exclusion criteria including: Inability to take a pill; Drug hypersensivity.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bruxism. Timepoint: 2 Weeks, 1 Month , 3 Month after adminstration. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intensity, Frequency. Timepoint: 2 Week, 2 Month, 6 Month. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Sayed Nasser – Mostafavy, Dr Majid Khademian
Vice Chancellor for Research, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan,
Outcome results
None listed